BBNA
JAZZ icon

Bremer Bank National Association’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bremer Bank National Association’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,128
Closed -$146K – 461
2019
Q1 		$146K Buy
+1,128
New +$147K 0.03% 288

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Bremer Bank National Association's JAZZ Position: Q2 2019 in Review

Bremer Bank National Association sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2019, closing a stake of 1,128 shares — an estimated $146K sold.

Bremer Bank National Association first reported a position in JAZZ in Q1 2019 and held it in 1 quarter. The position peaked at $146K in Q1 2019. 416 funds tracked by Wall St. Rank hold JAZZ as of Q2 2019.

  • Bremer Bank National Association reported no remaining Jazz Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Bremer Bank National Association sold 1,128 Jazz Pharmaceuticals shares in Q2 2019, an estimated $146K.
  • Bremer Bank National Association first reported a position in Jazz Pharmaceuticals in Q1 2019 and held it in 1 quarter.
  • Bremer Bank National Association's Jazz Pharmaceuticals position peaked at $146K in Q1 2019.
  • 416 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2019.

Based on Bremer Bank National Association's 13F filing for Q2 2019, filed 13 Aug 2019.